Advertisement Catalent names new interim president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Catalent names new interim president and CEO

New Jersey-based Catalent Pharma Solutions has appointed George Fotiades as its new interim president and CEO.

John Lowry, the incumbent in this role, is leaving Catalent to pursue other opportunities, and the search for a replacement is now under way, the company said.

Mr Fotiades has served as chairman of the board since Catalent’s creation in 2007, and will continue to serve in that capacity. Mr Lowry will be assisting Mr Fotiades during the leadership transition.

Mr Fotiades said: “I would like to recognize John Lowry’s important contributions to Catalent over the last seven years, and particularly the leadership continuity and focus he brought during our transition to a standalone company. I am also pleased to assume an even more active role during this transition to help drive Catalent’s future success.”